ArticleFrontiers in pharmacology2022

Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer.

Masaki Hirabatake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.